Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What if you had 10 partners that paid a royalty of 15% and an upfront fee for 'x' years without giving up equity. You could also segment out some treatment that you retain if there is no approved combo in that treatment area.
I think this would be good vs giving equity away that would potentially limiting relationships for various treatments.
I agree it is normally for cash rich mature companies but I would rather see some funds spent on a buyback than any potential RS. If this would help get our price up to get back to NYSE or NASDAQ then institutional investors could come in driving up the price more and we could then sell the repurchased shares at a higher value.
I would buy more if I saw Linda and Les buy $500k each.
Always good when leadership buys in vs gift themselves shares.
I requested clarification yesterday regarding Flashworks and MIA after the ASM.
They stated the MIA currently does not include Flashworks. This is just clean rooms, facilities, and processes currently.
I believe we should all just focus on January milestones which I see as:
1 - MIA approval
2 - Spoofing Lawsuit Activity mid-month
a - dismiss or allow it to move forward
b - if it moves forward will a settlement offer be made and accepted or declined
c - if declined will it settle during discovery or just prior to trial
Whenever settlement occurs what are others opinions of what to do with funds? These are in order as I would like to see them priortized.
1 - Stock buyback to raise stock price
2 - Restart Dcvax Direct trail
3 - Additional buildout of Sawston cleanrooms
4 - Flashworks unit build complete and multiple units built once approved via another round of MIA approvals.
5 - Fund combo trials once we have Dcvax-L
MAA approval so we are in a position of strength.
I would like to see a significant amount go to stock buyback to push us over the top and get us to NYSE or NASDAQ so we can get the big institutional investors to assist in the climb out of the cellar.
I am not a fan of a BO or any equity partnership or JV. I believe a JV/P may push other BP to not work with us as some proceeds would benefit a competitor. NWBO needs to get to a position of strength and only do a licensing agreements with an upfront payment and ongoing royalty payments. I can see doing the first agreement at a discounted licensing and royalty fee to drive urgency; thus, get the ball rolling!
I believe a hub and spoke model would be best - similar to the analogy someone used recently of Coca Cola and its bottlers.
This is truly a platform technology and should not be held by one BP as it will enhance many products as LL slide showed in one of her recent presentations.
Happy New Year to all Longs!
Stay STRONG and buy on the dips if you are so inclined!
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
These are my personal thoughts and should not be considered investment guidance. Just throwing darts and spinning yarn.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Great article to learn about The Short Mafia and AF.
The article was posted on February 1, 2021, but is very relevant to the current activities as we all know there were more shorts sold on May 10th, 2022 than reported (15mil of the 77mil total sold).
The Short Mafia Article
Love the initial picture in the article - we need to see more "X" over the headshots. I do believe people are putting themselves in the crosshairs of the authorities as some have done this for years allowing groups to gather information and connect the dots.
If what Michael Bigger tweeted is valid and threats are being directed at NYAS and Linda (as I have heard as well) then what is to say this is not the delay we are seeing with the journal article. Are the journal or peer reviewers being targeted or just fearful after what appears to be occurring?
ASCO will be interesting as I hope we see Dr. Liau and Dr. Ashkan speak as I believe they are teaching doctors and scientists they can speak to the data vs a company official as they appear to still be in a quiet period with TLD not official and fully released via the company. Of course, this is all held up by the journal article still pending.
We all need to push the various entities and people that may have been harassed or threatened to stand tall, report the activity to authorities, continue the good work to cure cancer, and give cancer patients a fighting chance to live longer with a much better quality of life.
Please fight the fight Dr. Liau, Dr. Ashkan, UCLA, NWBO, and all others that are part of this great advancement in cancer treatment!
Thank you NYAS for standing up to the short bullies, requesting that Dr. Liau present and peer-reviewing the data - may others take note and do the same.
Can you imagine growing up wanting to be a shorts bully - wanting to kill companies, put people out of work, kill innovation, and kill patients? What a messed-up childhood and poor parenting. These guys are no different than the old school mafia enforcers that broke fingers, arms, legs, necks, and straight-up murdered people. These are the people we all want out of our communities, behind bars, wearing striped jumpsuits!
Last note, I believe we should see something shortly on the ASM date as the meeting should be no later than June 18th, which is 13 months, to the day, from the last ASM. This would be a Saturday making it easy for investors to attend in person.
STAND UP TO CANCER - this includes financial cancers like the short mafia!
Best of luck to all longs!
How do you beat a bully?
Punch him in the nose or kick him in the balls!
NWBO - Linda, Les, and the BOD give them our lunch money instead ($1bil in shareholder value).
Unfortunately, Linda and Les appear to be working with AF and the shorts. They have taken no action publicly to address the shorts beyond adding and overpaying Cofer Black for basically his name. Wes Christian is also a paid consultant - we have seen no results from Cofer, Wes' or others' research. I understood that this would be used in the future once we are beyond TLD; however, I fear the future may never come. They should have enough to punch or kick the shorts into their place at this point; otherwise, we will be bankrupt shortly and the assets sold.
Why do I say this -
Les repeatedly stated they would provide TLD and a journal publication, but this has not happened 19 months past the data lock.
Les and Linda have stated that they were going to create the greatest short squeeze ever.... we have seen only repeated short attacks, with the latest on May 10th yielding a 1+ billion-dollar devaluation of the stock via a stand-alone scientific presentation.
NYAS conference presentation was during a quiet period with no other events to support the share price. I have thought about this since May 10th running various scenarios to figure out what the benefit would be, and cannot think of a benefit to shareholders. The short attack allowed many of us to pick up more shares cheaply; however, I believe we would all prefer to have a higher share price, TLD, journal article, BLA submission to all four RAs, combination treatments with Keytruda status update, etcetera, Dcvax Direct trail startup status, and or announcement of a JV/BO. Most of all, patients see the light at the end of the tunnel with a vastly better treatment nearing.
We hear that AF harassed UCLA, UPenn, NYAS, and Linda Liau. Was this one reason she did not present virtually at NYAS, as it appears her COVID case was mild. If this is all true - have any of the entities or Mrs. Liau reported this to SEC, FINRA, FBI, or other authorities.
I agree with Michael Bigger the BOD needs to commit and step up to crush the shorts or get out and allow others that understand shareholder fiduciary responsibilities. PULL THE BLANKET OFF THE SHORTS NOW!
I hate to agree with AF and the recent articles from AACR and Cancer Connect that the trial failed to meet its primary endpoint per the clinical trials website. Their articles are factual when one does a simple check of clinicaltrials.gov even though the company had rewritten its SAP and it was updated on two trial sites in Europe. This was a conscious decision by Linda and Les not to update the US and Canadian trial sites since 2016. This was a poor decision as we currently pay the price ($1+bil in shareholder value). I am a firm believer in taking my medicine sooner rather than later. AF was going to jump on this then and again, but it would have been much more muted now (not a $1bil hit) and would have put NWBO in a position to defend vs. the current silent treatment during the quiet period.
We need leadership that is accountable, responsible, honest, trustworthy, communicates publicly often, delivers RESULTS, and understands fiduciary responsibility.
This continued finger-pointing and blame game is getting us nowhere. Still, diluted shares and cancer patients dying as Linda, Les, and the BOD twiddle their thumbs and shirk responsibility to shareholders.
When this company became a public company, Linda assumed a fiduciary responsibility. She needs to take the responsibility seriously and perform in the shareholder's best interest. If she and her team cannot, they need to sell the technology or bring in leadership that can perform and maximize shareholder value. The same goes for the BOD!
BTW, Les and Dave need to understand being busy does not mean you are being productive.
For those on the board giving Linda and Les a pass for last week, you are part of the problem – people like AF and MidwestHegie are not journalists; they are like CNN opinion talking heads and are looking to spin things their way and will look for what fits their narrative. AACR and Cancer Connect articles are correct because NWBO failed to request to update trial sites since 2016. The journalist validated like many do these days using other articles (AF via Stat) and the US Clinicaltrials.gov site as well they are US-based.
Also, I would like to address a comment about Michael Bigger requesting the BOD commit to addressing the shorts or get out. I am pretty sure he is currently making a small profit in the investment but not where he expected to be at this time. If Michael continues to see inaction by the BOD, he will sell his shares and move on to a more profitable investment with more decisive leadership. This would drive down the share price as he works through his exit strategy. Is that really what you would like to see? I hope the BOD takes him seriously and understands many other long-term shareholders are on the same page with him with their concerns. Therefore, he should not be treated as a minor retail investor.
BO vs JV/Partnership -
At one time, I really wanted a BO but over time as I started wanting to hold this for 4-7 years after the TLD of DcVax-L as I believe this has the potential to outperform Amgen as the company buys back shares so I started leaning toward JV/Partnership. However, at this time I would be happy with a quick buyout at $20-$25bil as leadership's failure last week and continued silence on all topics leaves me very concerned about the future of the company - I believe in the science just not the management. As my friends and fellow investors say "In Linda Liau we Trust - Linda and Les not so much!"
I suggest Linda, Les, and the BOD should be concerned about a shareholder revolt with a potential lawsuit concerning fiduciary responsibility if they do not right the ship quickly!
To do so they need to -
1) Correct the clinical trial sites to all match the EU and German sites.
2) Provide TLD
3) Journal Publication (Annals of Oncology, Lancet, NEJM level of Journal)
If AF is harassing the journal or the peer review process then this needs to be
addressed swiftly or we need to forgo the journal as this just continues to allow
the shorts to control the narrative - (self-publish) and discuss at ASCO.
4) Provide status at ASCO and via PRs
5) Status of filing all 4 BLAs to the RAs
6) Provide status of patents (DCVAX and Flashworks)
7) Provide Sawston compassionate care numbers of cases completed, count of patients signed up, and dollars
8) Status of DCVAX - Direct
9) Status of any combo trials using DCVAX technology
10) In-person ASCO so you are face to face with your investors.
Sorry for the long rant. I do not post on here frequently and needed to vent after last week's leadership fiasco.
NWBO BOD, Linda, and Les - Stop hiding behind 1on1 conversations and plausible deniability, start attacking the shorts by publically outing them via lawsuits, start delivering results, and meet your fiduciary responsibilities! Stop the excuses, and fingerpointing, accept responsibility, communicate publically and often, be accountable, and execute swiftly!
Response to Hoff's impressions from talking with a company representative
_________________________________________
Quote -
Current leadership
- It isn’t about the money
_________________________________________
I have talked to probably the same company representative and will be having one last conversation with them this week. After comparing notes with fellow long-term investor friends that talk to two representatives at NWBO I have decided it is not worth the effort and mental energy any longer - so my last call with them will be a challenge for them if the above statement is true.
If it isn't about the money then why has Linda set up so many companies around NWBO to funnel money from various parts of the process? Below is a list of companies that appear to be somehow related to or invested around NWBO. One could see this as limiting the value of NWBO as these are external to NWBO.
Toucan, Cognate, Advent, Aracaris Capital Limited, Aracaris Limited
If it isn't about the money then why was there a true-up for her and others when the common shareholder did not get a true-up. We had to true-up at our own expense or be diluted.
If it isn't about the money then wouldn't it be easiest for her and the other true-up recipients to just return the shares vs the expense of a trial.
If it isn't about the money then why convert loans from a simple interest return to warrants that could yield millions of dollars.
If it isn't about the money then why not give back all those warrants, options, and gifted shares so no proxy vote for additional shares is required.... thus, shareholders are further diluted or at risk with additional investment to true-up.
I understand there were family members that got both Linda Liau and Linda Powers involved in GBM. However, the only one that seems to be truly altruistic is Linda Liau and her team at UCLA.
I believe Linda Powers is purely about herself wanting to be hailed as the one that got this to the market getting past all the hurdles... mostly self-imposed! She wants generational wealth as seen through all the warrants and various companies she will generate cash flow from. She will not partner with others to move this forward at a quicker pace because she is paranoid from the shorts of the past as one of her excuses, along with Covid and not having resources (funds or people).
If we get past ASCO and have no TLD and top tier Journal article this will crater to the point there will be a need for further dilution as no funds from exercised warrants will be coming in.
She talks "pedal to the metal" but she has talked about the trial being completed in 18 months in 2011..... and 2018, 2019, 2020, 2021...... She got in over her head and is too full of pride to ever state this fact.
One representative stated 1-4 months at three different times last year to various people.... all the 1-4 month windows were different. Of course, attorneys love to hide behind plausible deniability; thus, all the sidebar conversations and no PRs from the company - but they are able to use the shorts as the reason for no PRs not their need for plausible deniability. If they would meet their self-imposed public or private timelines they would have credibility and the shorts would be cut-off at the knees. Instead, they put out high-level milestones (with I bet intermediate steps being added as needed - equals delays) losing credibility.
Many things are out of their control but there seems to be an inability to impart a sense of urgency to others to go the extra mile for current and future cancer patients.
One representative told me I had never worked in this field and do not know the details of what needed to be done in this undertaking. I think it is obvious that Linda, Les, Dave, the SAB, the BOD, and others do not know all the steps either; thus, all the delays as they stumble and bumble their way through this process.
I get that this is a paradigm shift in cancer treatment, many others have failed, and there are many moving parts including regulators (drug and patent) but this has to conclude shortly as many people are dying daily from GBM and every day it doesn't move forward DCVAX Direct is delayed allowing even more people to die! I am tired of seeing friends pass from cancer or go through the current SOC in an attempt to survive.
Sorry for the rant but statements like that "It isn't about the money" is bull squirt when Linda Powers has her hands in so many money pies around NWBO.
In Linda Liau and the UCLA team, I TRUST - In Linda Powers, Les Goldman, SAB, BOD, and the firm not so much.
Will LPowers hide behind covid again and not have an in-person ASM this year? They could do the meeting in a state with fewer restrictions like Texas or Florida. I am sure the ASM will be around June 18th as they will use the full 13 months allowed.
Feel free to throw stones and give me crap but after 9 years being invested, 18 months with data lock, and no TLD yet I believe I earned the right to rant occasionally.
Journal Article and Share Proxy Vote Timing & Shares
I was wondering which journal article my fellow longs believe the data will be published in.
I was thinking of the Lancet (as we appear publically to be advancing quicker in Europe) but after various conversations and seeing the External Controls article recently that Padzur and the FDA team were recently published in the Annals of Oncology I have shifted in my thinking to the EMSO Annals of Oncology. It looks like the EMSO AoC publishes articles at random dates as well so that would help catch naked shorts off balance.
I have also been debating with my advisor and another friend regarding the timing of the proxy vote to increase shares - before or after TLD? We have also discussed the number of shares increase to the minimal amount needed to cover the restricted warrants or will they push the total up to say 1.750 billion or 2 billion?
As Stuart Varney states - "What say you?"
Feeling bullish so I purchased 4000+ shares yesterday and have orders in for another 10,000.
Joan, Michael, Carlo - Current State of Affairs
Well, it looks like Joan's most recent article had no real lasting impact on the stock like it did the first time she published an NWBO article. BTW, she needs to move from Florida if all she is going to do is be a flaming miserable liberal and bash the orange monster and DeSantis she would be better suited living in NYC or California!
I think Michael Bigger and Carlo Rago have also lost their ability to impact the stock as well with their money and white paper.
It all boils down to TLD, The Peer Reviewed Journal Article, a conference presentation, Flashworks, and Drug Approval to make the stock move significantly in a positive manner. Nothing else really matters and all discussion is simply a waste of mental effort and hot air.
This begins my 9th year of holding this stock and all the languishing, excuses, covid, lack of funds, shorts, self-inflicted wounds, overly positive senior leadership comments, leadership adding additional hurdle after additional hurdle, etcetera are getting tiresome.
Time for Lyin Linda and Les to come clean and bring forth TLD and The Peer Reviewed Journal Article and let the Data and Actions speak for themselves.
From there we can move forward with a BO, partnerships, DCvax Direct Trail, and move back to NASDAQ or to NYSE to begin unleashing the stock value for investors and providing relief to cancer patients.
All other discussions around stock price guesstimates, business direction, trial results, are just wasted mental exercises and useless use of your time when more productive efforts can be found versus wasting another year on IHUB, Twitter, etc.
Happy New Year and may this misery end in 2022!
TLD Announcement this week???
An investor friend has put together the puzzle pieces from all the information Linda and Les have put forth in public and believes the TLD will be announced soon. Below is the logic and timeline.
What are your thoughts on the logic, timeline, and potential price if this happens or doesn't happen?
FOMO
Logic -
1) Linda and Les want the greatest short squeeze of all time.
2) Linda and Les know that investor, medical, and pharma communities what to hear from Linda Liau peer community as they have the credibility that Linda P and Les are lacking after missing the timelines for so many years.
3) Linda and Les have stated repeatedly they want to have multiple events occur in quick succession to create a short squeeze and this includes a peer-reviewed journal and conference presentations.
4) SNO is releasing Late-Breaking Abstracts on the second day of the upcoming conference vs 1 or 2 weeks prior as they have done for several years.
5) 14 UCLA doctors making the cross-country trips to make various presentations at SNO.
6) Marnix Bosch to make a presentation on GBM Past, Present, and Future in January which Les has mentioned Marnix would make a presentation after TLD as a follow-up.
7) 4-6 opportunities for publication in journals including NEMJ, Lancet, JAMA.
Timeline -
1) November 17th - TLD prior to market open with mention of the journal release later in the day.
Stock appreciation occurs short caught off-guard - starts.
2) November 18th - News Coverage
Additional information drips out as the conference starts.
Stock appreciation occurs short trying to cover while they lose millions or even billions - continues.
3) November 19th - LBA provided the second day of SNO with a presentation added for the Queen of SNO - Linda Liau.
Stock appreciation occurs short trying to cover while they lose millions or even billions - continues.
4) 14 UCLA participants along with NWBO representatives at the conference that can help address questions from the medical and pharma community.
Stock appreciation occurs short trying to cover while they lose millions or even billions - continues.
5) Shorts messing their pants all weekend as travel plans are canceled as they try to save their money be lost in the greatest short squeeze of all time.
Stock appreciation occurs short trying to cover while they lose millions or even billions - continues.
6) Short squeeze continues into a holiday-shortened week for investors.
Shorts to get burned turkeys for Thanksgiving and a Lump of Coal for Christmas.
AF crawls into his hole to never be heard from again.
Stock appreciation occurs short trying to cover while they lose millions or even billions - continues.
7) Cancer patients see hope is just around the corner with FDA, NICE, etc approvals are near.
Investors enjoy a great Thanksgiving and Christmas content in knowing it was all worth the wait and the gift of relief for patients is the best gift of all!
Stock appreciation occurs short trying to cover while they lose millions or even billions - continues.
8) Sawston gains approval just before Christmas as the final present under the Christmas tree for all believers.
AF's hole is sealed forever to serve as his final burial crypt as a short-friendly so-called medical/pharma journalist.
Stock appreciation occurs short trying to cover while they lose millions or even billions - continues.
9) January - Sawston starts production for 45-50 patients per month
January - Marnix speaks on GBM treatments Past, Present, and Future
January - Emergency and or Fast-track Approval applied for with all drug approval boards in the US, UK, Europe, and Canada.
Stock appreciation continues and shorts are toast and completely soiled themselves as they are beaten at their own game.
10) Summer - DCVAX-L has gained approval in socialized medicine countries and nears FDA approval.
DCVAX Direct trials are ramping up both standalone and combinations with other drugs.
Big Pharma starts to line up for partnerships
Cofer Black makes his appearance with lawsuits against the shorts and their backers.
The stock continues to appreciate with every announcement!
Shorts well.... they realize they committed financial suicide! The short game has short-term benefits vs long-term gains for all of us long-term investors.
Cannot wait to see the Queen of SNO make her appearance!
Best of Luck To All Longs!
This is too funny! Enjoy!
Back to my cup of coffee and work!
TLD Announcement
An investor friend has put together the puzzle pieces from all the information Linda and Les have put forth in public and believes the TLD will be announced soon. Below is the logic and timeline.
Logic -
1) Linda and Les want the greatest short squeeze of all time.
2) Linda and Les know that investor, medical, and pharma communities what to hear from Linda Liau peer community as they have the credibility that Linda P and Les are lacking after missing the timelines for so many years.
3) Linda and Les have stated repeatedly they want to have multiple events occur in quick succession to create a short squeeze and this includes a peer-reviewed journal and conference presentations.
4) SNO is releasing Late-Breaking Abstracts on the second day of the upcoming conference vs 1 or 2 weeks prior as they have done for several years.
5) 14 UCLA doctors making the cross-country trips to make various presentations at SNO.
6) Marnix Bosch to make a presentation on GBM Past, Present, and Future in January which Les has mentioned Marnix would make a presentation after TLD as a follow-up.
7) 4-6 opportunities for publication in journals including NEMJ, Lancet, JAMA.
Timeline -
1) November 17th - TLD prior to market open with mention of the journal release later in the day.
Stock appreciation occurs short caught off-guard - starts.
2) November 18th - News Coverage
Additional information drips out as the conference starts.
Stock appreciation occurs short trying to cover while they lose millions or even billions - continues.
3) November 19th - LBA provided the second day of SNO with a presentation added for the Queen of SNO - Linda Liau.
Stock appreciation occurs short trying to cover while they lose millions or even billions - continues.
4) 14 UCLA participants along with NWBO representatives at the conference that can help address questions from medical and pharma community.
Stock appreciation occurs short trying to cover while they lose millions or even billions - continues.
5) Shorts messing their pants all weekend as travel plans canceled as they try to save their money be lost in the greatest short squeeze of all time.
Stock appreciation occurs short trying to cover while they lose millions or even billions - continues.
6) Short squeeze continues into a holiday-shortened week for investors.
Shorts to get burned turkey's for Thanksgiving and a Lump of Coal for Christmas.
AF crawls into his hole to never be heard from again.
Stock appreciation occurs short trying to cover while they lose millions or even billions - continues.
7) Cancer patients see hope is just around the corner with FDA, NICE, etc approvals are near.
Investors enjoy a great Thanksgiving and Christmas content in knowing it was all worth the wait and the gift of relief for patients is the best gift of all!
Stock appreciation occurs short trying to cover while they lose millions or even billions - continues.
8) Sawston gains approval just before Christmas as the final present under the Christmas tree for all believers.
AF's hole is sealed forever to serve as his final burial crypt as a short friendly so-called medical/pharma journalist.
Stock appreciation occurs short trying to cover while they lose millions or even billions - continues.
9) January - Sawston starts production for 45-50 patients per month
January - Marnix speaks on GBM treatments Past, Present, and Future
January - Emergency and or Fast-track Approval applied for with all drug approval boards in the US, UK, Europe, and Canada.
Stock appreciation continues and shorts are toast and completely soiled themselves as they are beaten at their own game.
10) Summer - DCVAX-L has gained approval in socialized medicine countries and nears FDA approval.
DCVAX Direct trials are ramping up both standalone and combinations with other drugs.
Big Pharma starts to line up for partnerships
Cofer Black makes his appearance with lawsuits against the shorts and their backers.
The stock continues to appreciate with every announcement!
Shorts well.... they realize they committed financial suicide! The short game has short-term benefits vs long-term gains for all of us long-term investors.
Cannot wait to see the Queen of SNO make her appearance!
Best of Luck To All Longs!
Hi all and DI,
I am a long-term investor (2013 - 120,000+) that has followed this board for several years and enjoy reviewing the nuggets of gold that you all bring to the board.
I believe in the DCVAX science; however, like many of you, I have growing concerns about the companies leadership abilities to get this to TLD, regulators approval, and market.
I was shocked to see that Dave Innes apparently has time to troll the message board and is using material from it to respond to other investors. I would assume he could do better than that. I do understand they are in a "quiet period" but I think he could have done better or just keep quiet altogether and focus on getting us to TLD, approval, and market.
I was hoping for some form of public communication on the anniversary of the locking of data on October 5, 2020; instead, we get an AF article on October 6, 2021.
With Dave following the board, I would like to get his and the other IHUB NWBO board member's thoughts.
Dave - When will we receive a voting proxy to increase the share count to cover the suspended warrants that exceed the current share count?
Dave - How many shares will LP and LG receive for a "job well done" in further diluting shareholders?
I certainly hope the journal we all seem to be awaiting is a highly credible journal vs the lower tier JTM journal.
Fellow Board Members what are your thoughts on voting for additional shares to cover the warrants that LP and LG provided to themselves and others?
Also, what are your thoughts on giving them additional shares on top of their current shares as a reward for all the good work they have done the past couple of years?
Fortunately, I have sold some of my original 160,000 shares to get my cost basis to $0; thus, de-risking this investment because of the concerns with the company leadership.
DCVAX Dreaming!
Best wishes all!
Yep! Show's I do not follow this much anymore.... Basically, I have already written off the $70k investment I have made in this floating turb.
Need to find some toilet paper!
Meirluc - TOP LINE AND DATA LOCK -- LP, DI, LG, SAB and BOD
I get what was said during the ASM as I gave 30 minutes of my life for that waste of time.
All the queries could already be resolve or just being finalized, etc. My point is they have never hit a timeline and have ZERO credibility. Why should be beleive them now.... My end point is deeds mean a heck of a lot more than repeatedly missed timelines.
So when they start showing a trend of meeting self-imposed timelines they will begin to gain credibility with patience, investors, main street, wall street and big pharma..... Until then they are just pissing in the wind!
Meirluc - you have been here long enough to have see them in action.... stop drinking the cool aid they be dispensing...
TOP LINE AND DATA LOCK -- LP, DI, LG, SAB and BOD
Are there any bets in Vegas on the actual timeline NWBO will data lock, top line data or provide another excuse as to yet another missed timeline. Why are you all believing them with this timeline as they have missed so many over the years - absolutley not creditbility left with these yahoo's.
Of course, never their fault..... hahaha
I certainly hope I am wrong for both investors and patience. I would love to see everyones picks
DATA LOCK and TOP LINE DATA - Bet they are not within the three month window. Pick your weeks for each to actually occur!
Week 21 May 17, 2020 May 23, 2020
Week 22 May 24, 2020 May 30, 2020
Week 23 May 31, 2020 June 6, 2020
Week 24 June 7, 2020 June 13, 2020
Week 25 June 14, 2020 June 20, 2020
Week 26 June 21, 2020 June 27, 2020
Week 27 June 28, 2020 July 4, 2020
Week 28 July 5, 2020 July 11, 2020
Week 29 July 12, 2020 July 18, 2020
Week 30 July 19, 2020 July 25, 2020
Week 31 July 26, 2020 August 1, 2020
Week 32 August 2, 2020 August 8, 2020
Week 33 August 9, 2020 August 15, 2020
Week 34 August 16, 2020 August 22, 2020
Week 35 August 23, 2020 August 29, 2020
Week 36 August 30, 2020 September 5, 2020
Week 37 September 6, 2020 September 12, 2020
Week 38 September 13, 2020 September 19, 2020
Week 39 September 20, 2020 September 26, 2020
Week 40 September 27, 2020 October 3, 2020
Week 41 October 4, 2020 October 10, 2020
Week 42 October 11, 2020 October 17, 2020
Week 43 October 18, 2020 October 24, 2020
Week 44 October 25, 2020 October 31, 2020
Week 45 November 1, 2020 November 7, 2020
Week 46 November 8, 2020 November 14, 2020
Week 47 November 15, 2020 November 21, 2020
Week 48 November 22, 2020 November 28, 2020
Week 49 November 29, 2020 December 5, 2020
Week 50 December 6, 2020 December 12, 2020
Week 51 December 13, 2020 December 19, 2020
Week 52 December 20, 2020 December 26, 2020
Week 53 December 27, 2020 January 2, 2021
DI, LG and LP..... where's the _______ !?!?!?
Thanks for the nothing burger you served April 18th and for the past few years. Of course, I found it interesting that we are still gathering missing data..... I had heard that data collection would easily be completed well in advance of the SAP being completed and that we would only need two or three small rounds of fundraising from friendly's. Looks like both were lies and further evidence that you all cannot manage your way through anything... Suprised you are able to get up, shower, and dress yourselves daily.
We have had to deal with several rounds of dilutions while data is still not gather. Another timeline provided that you all will prove you can miss again.. Pitiful you all enjoy setting your selves up for failure and playing games with investors and patients! Can we get real leadership vs the garbage we have dealt with for years? What is the next excuse you will provide? Specific timelines that are met matter but you again spoke in generalities that lead to a variable timeline adn investors to guess again as evidenced by messages on this board.
Where's the_______!!!!
Hope you enjoy the read DI you are worthless in your role and hope you understand you have lost a lot of credibility you may have built up over the years of your career!
ahhhh. Python and Matplotlib or Seaborn....
Sniff, Sniff, Sniff ---- LP, LG and DI
Hope everyone has their rubber boots because that is the manure Linda, Les and Dave will be shoveling tomorrow that we smell.
Question is do we waste our time even dialing into the ASM or just check the opening price Monday morning as we all now if there is not something truly "interesting" like data unblinded or TLD or if we bought the Lipsticked Pig that no longer has lipstick. A new timeline or words stated to create confusion / that can be construed in various ways or all worthless as NWBO will have no creditability until they have an approved marketable product. All else is irrelavent information and Linda is just blowing carbon into the atmosphere talking about anything else.
From reading through the board and seeing no PR from DI and LG / NWBO looks like there will be more excuses.... around being a small company is impeding their ability to get the funding and do thinks quicker like BP. In reality they are like all those folks in DC that have no sense of the of the impacts to patients and investors as they continue to be tone deaf and drag this out.
They just need to come clean with the results and exactly where they are at so we can all decide to let it go or cheer. With that being said I will not sell for several years as I beleive this could be LP and her friends trying to drive the price down themselves to buy them cheaply and take the company private..... Who knows there are hundreds of theories about why they are really dragging their feet... whether it be they know it failed and are just drawing salaries (creating personal family weatlh) to just poor management skills and paranoia about shorts trying to bring down the company. They are long gone as the damage has been done so who cares about AF, shorts or Larry Smith pumping.
If this fails I feel most sorry for patients and Linda Liau and team as I beleive this failure will fall primarly on LP and the NWBIO leadership team including the BOD and SAB.
I have stated before that ACCOUNTABILITY is needed and that is why I voted against the two items in the proxy and 1 year for their salaries.
Good luck to all we will cheer, cry or have the pain continued this weekend.
LP, LG and DI be honest and transparent with your investors and patients - stop providing false hope for all and be real for once in your effing life.
Dave you should have stayed at Oppenheimer as your career is sullied long term hanging out with these goobers. You are what you run with......
"Words with Friends" (LP,LG,DI)
It has been interesting to watch the response of the msg board concerning the 10-K and parsing out each word and comparison to prior 10-K. We need to forget about parsing words and reading into things as that only drives thoughts and creates frustrations.
Move on from "Words with Friends" that LP, LG and DI want you to play and demand Deeds, Actions, Results and lastly Accountability.
"Words with Friends" is a game you only lose and waste many cycles of energy!!!
Demand DARA!
Regards!
LP - Urgency, No More Excuses, and Accountability.
There appears to be no urgency with Linda and the team. They just keep issuing stock and missing timelines using the same excuses over and over. If they state they need another month it will drag out to 6 months or more. Remember February 2019 it was pedal to the medal and here we are 14 months with another ASM and nothing but dilution in between. As I mentioned before, we have to stop doing the same thing over and over and expecting different results.
I am not going anywhere as I have over 150,000 shares but well underwater and have basically written this one-off as I am frustrated and feel that Linda needs to be held accountable as the BoD is not doing it. Like it is her own personal business using other's funds and giving herself lots of shares or warrants.
I get I am not from the Bio or Pharma industry and do not understand their processes. I do understand projects, gathering requirements, learning the business prior to engaging in it, listening to SMEs and using my own funds if I do not want others input.
DI's Infomercials...
No, I would not believe any of DI's infomercials that I have heard about... He just continues to push the excuses I have mentioned previously and adds no real value - just another expense.
Dave is just a yes man reading a script as you stated LP. I have many concerns about LPs' public leadership style that we have seen over the years.
If LP, LG, and DI have NO TLD or Unblinded Data at ASM...
If they do not have either of the above by or at ASM I am guessing a nickel a share. That will require major dilution if she can find a buyer for them and give them an untold number of warrants. That's why I think bankruptcy is the only thing around the corner if they do not bring something more than "interesting" to ASM. Something that will move the share price up to $1 or more as she needs to get some warrants cashed in vs requesting the addition of more dilutive shares. She needs to quit taking the easy way out at the expense of others - it's called accountability and respect for investors and patients.
If Linda cannot get share price above a dollar she is not worthy of the CEO title. They have to get real leadership that is trustworthy as Linda and the team have lost credibility with what appears to many retail investors and some friendly investors.
Linda Powers and stats/SAP.
I looked up the stats company - they are based a few miles from DC..... Look's like the owner, a director, and a junior stats person wrote up the SAP. The names were listed in one of Marnixs' most recent presentations....
Linda, BoD, and SAB - Accountability is Required!
Linda, Les, DI, Marnix, the BoD, and SAB need to deliver something more than "interesting" at the ASM. Accountability!
I agree with your comments here Umibe and to my previous message. I, too, believe they will need to gain approval for additional shares, and if something more than "interesting" is not released before or at ASM, then the stock will take a more dramatic price drop - requiring many shares to be sold at an even more depressed price if she can even find a buyer.
This has been my concern for over a year as Linda and team or singular-focused, think they can keep missing deadlines and not communicating and thinking they will have the support of retail and friendly investors. I am afraid they live in a vacuum (like most in DC) and do not realize that not unblinding or releasing TLD soon will drive the company to bankruptcy. Have to look at the bigger picture.
I do not believe anyone will accept another timeline, as I stated earlier that they have no credibility because of there long history of not adhering to their schedule.
They also need to understand the same old excuses being a small company with few resources (staff, funds, expertise, etc) will not continue to be accepted. There have been ways out of this box, but Linda has allowed her ego and desire to prove her point to be right, at the expense of patients and shareholders.
Linda needs to get her ego out of the way and work with big pharma to deliver both the drug to market and shareholder value. There appears to be no focus on shareholder value. Hence, we continually see stock price diluted as she sells shares to friendly buyers that are starting to see they are holding worthless paper as they see the same pattern of ineptness.
If she continues the same actions, she will continue to get the same results, and many will die. Shareholders' investments will go to zero - including her 29mil shares and her friendly investors, will turn on her as well. Thus, I do not think she understands the gravity of this ASM and needs to provide unblinded data or TLD by ASM.
Northwest Biotherapeutics does not have infinite time! DCVAX appears to be a great platform but poor corporate management by an attorney and others is squandering a great platform.
Time for transparency and no more leading statements - Accountability and Results are Required.
DI please ensure Linda gets it right this time.
Video of Linda Powers talking at ASM.
Hope you find it "interesting"....
Linda Powers at ASM
Hope DI, LP, LG are working out a good story for the need to do another shelf offering but are unable to provide any tangible unblinded updates on the data. Maybe it will be the "interesting" event will be they finally admit to being inept! The have more data than any other similar drug (supposedly better than any other drug) and they cannot seem to release information and submit the SAP to the FDA, etc. makes you go HMMMMM!!
If the proxy is a shelf offering I will vote No and if it is to replace executives it is Yes.
Call me frustrated and tired after watching the games for 6+ years and all the leading statements to keep people believing in management. True leaders only make statements that they can deliver on and do not throw words out like 'pedal to the metal' and 'interesting' leading and then blame it on shorts, not enough funding, etc. They only set themselves up for failure and look foolish acting like they have a lot of things out of their control when in fact they can control much of the situation. Linda and Les have taken being an executive down below used car or timeshare salesman.
On another note - Looked at airline prices today for ASM. Of course, prices have gone down as the airlines struggle with Corna. Will probably lock in a ticket this weekend - 1st Class only $550 non-stop round trip with Main cabin being $260.
I see lawyer's circling like the vultures they are.
That's my frustrated rant for the day! Hope everyone has a great day!
Which is NWBO like?
Chutes and Ladders, the "you almost had it fisherman", or old school Pong.
The carrot keeps moving as Linda and team continually find ways to slow the release of information by adding hurdles...…..
That works! Let's make DI, LP and LG and the lot work for their money!!!!
Please feel free to add questions and let's all select one to for the BOD, SAB and day-to-day management respond to. I have been in this for years and have friends that have had it for 10 years and we are all tired of the can getting kicked down the road and them selling allusions that the end is near and the data is near.
Alphapuppy - ASM Questions for David Innes, Linda Powers, Les Goldman, Marnix Bosch, Kevin Duffy, Jean Davis, BoD and SAB.
________________________________________________________________________
Hi Alpha,
Below is a previous post of questions I have for the ASM meeting as I see them kicking the can, yet again. The proxy will be a request for another shelf offering so they can further dilute the stock and live off their mismanagement. Any timelines provided are worthless as they have shown a vast propensity to not know how to adhere to one.
I have decided to go to the ASM so I can watch them lie to me in person.
They do not know how to be honest with their community of patients and investors. They are just good at talking out the side of their mouths and dangling the preverbal carrot.
I have pretty much written this invest off because of the mismanagement from the leadership not the hard work of Linda Liau and the researchers.
If this ASM doesn't go well I see .05 SP and lawsuits to waste any funds they get from further dilution.
________________________________________________________________________
I have been following the IHUB MB for a few years looking for nuggets of gold amongst the noise and gauging the temperature of other long-term investors and those that appear to be pumpers or shorts. I have been invested in NWBO since early 2014 and I am considering going to the ASM to asks some very pointed questions to the Company Management, Board of Directors and Scientific Advisory Board. This comes from frustration as an investor and seeing friends pass from GBM, other cancers that DCVax-L or Direct could have helped prolong their lives and/or give them a better quality of life through the treatment – it has truly been sad to see.
Are you going to ASM? Have questions you want to have addressed?
Either way - what are some questions you would like to hear the NWBO team address?
Let’s define the NWBO team as the following –
Company Management (CM) – Linda, Les, Alton, Marnix, Anthony, David,
Kevin, and Jean
Board of Directors (BoD) – Linda, Alton, Navid, Jerry, Cofer
Scientific Advisory Board (SAB) – Dr. Mac Cheever, Dr. Alfredo
Quinones-Hinojosa, Dr. Jerome Galon,
Dr. Samir N. Khleif, Dr. John Smyth
It would be great to get a list of questions compiled for them to address at the ASM meeting for the potential patients and frustrated longs. Is it too much to ask to provide a straight answer - not legal ease, posturing, words that are leading to speculation or open-ended? A real status, with a timeline for the next steps. At this point, with there being little to no trust in the long-term company management and David, maybe see the new blood Kevin and Jean get involved to provide some details vs the malarkey we have dealt with for years.
Yes, I know there are the AF's, CT's and some other rogue actors out there but Cofer is supposed to be watching all that and dealing with it in the future and we are already pretty much at zero financially so what is there to lose with some straight talk and transparency with investors.
Please chime in with your questions and let’s leave all speculation out of the thread to make it easier for David Innes to follow (we all know he reads this board). We do not need any more infomercials – we need some transparency to rebuild trust or new board of directors that will hold a new management team accountable. I’ll start with some below –
1) Specifically, address what activities have taken place since November 2018 with a timeline so we can see there is forward momentum and build up trust with your community (Doctors, Patients, and Investors)?
2) What steps, in order, are remaining to gain approval in each of the four RA’s with a timeline and what can be occurring simultaneously?
3) What activities are being undertaken to stop the dilution of share price to drive shareholder value and save/prolong people’s lives with minimal side effects?
4) If we continue to move forward at the current pace when will the current team step aside for leadership that knows how to get this to completion?
5) When will the company start doing arm’s length transactions?
6) Why will NWBO not partner with others to stop the dilution and get a product through the pipeline to patients?
7) Why does the company not focus on getting a single task completed vs spending time/energy/funds on other activities that are announced and never heard about again; thus creating false hope for the community and more broken trust. Items such as colorectal cancer with Merck and the UoMainz, DCVax Direct Phase next phase, Drug trails with Merck product, etc. These things just frustrate people and are a tease to both potential patients and investors alike generating many useless cycles of energy expended.
Please add your questions…..
8) ….
9) …….
10) ……….
11) Etcetera
I have a feeling if positive news is not announced prior to and/or at the meeting and if they are requesting an increase in shares, that this will be an interesting meeting for the management, not the investors or potential patients. It is time, we (longs and the angel investors) hold them all accountable (CM, BoD, SAB) and stop the slow drip insanity. Maybe NWBO’s insolvency will allow UCLA and Linda Liau to provide the license and technology to someone that will be successful in getting a new cancer platform to market.
I hope the answer to Question 1 above reflects they have been diligent and working smart the past 17 months (11/2018 – 4/2020), have unblinded, are completing preparation for TLD in "XX" days for the SAP and can provide a specific near-term week the four RA’s will receive the accelerated approval request.
Looking forward to seeing what all questions you longs have in mind and how many are going to ASM. Let's load this up over the weekend so David has some nice reading material Monday morning.
All the best and have a great weekend!
Gloom, Despair, and Agony!!!
NWBO ASM Questions for David Innes, Linda Powers, Les Goldman, Marnix Bosch, Kevin Duffy, Jean Davis, BoD and SAB.
_________________________________________________________________________
I have been following the IHUB MB for a few years looking for nuggets of gold amongst the noise and gauging the temperature of other long-term investors and those that appear to be pumpers or shorts. I have been invested in NWBO since early 2014 and I am considering going to the ASM to asks some very pointed questions to the Company Management, Board of Directors and Scientific Advisory Board. This comes from frustration as an investor and seeing friends pass from GBM, other cancers that DCVax-L or Direct could have helped prolong their lives and/or give them a better quality of life through the treatment – it has truly been sad to see.
Are you going to ASM? Have questions you want to have addressed?
Either way - what are some questions you would like to hear the NWBO team address?
Let’s define the NWBO team as the following –
Company Management (CM) – Linda, Les, Alton, Marnix, Anthony, David,
Kevin, and Jean
Board of Directors (BoD) – Linda, Alton, Navid, Jerry, Cofer
Scientific Advisory Board (SAB) – Dr. Mac Cheever, Dr. Alfredo
Quinones-Hinojosa, Dr. Jerome Galon,
Dr. Samir N. Khleif, Dr. John Smyth
It would be great to get a list of questions compiled for them to address at the ASM meeting for the potential patients and frustrated longs. Is it too much to ask to provide a straight answer - not legal ease, posturing, words that are leading to speculation or open-ended? A real status, with a timeline for the next steps. At this point, with there being little to no trust in the long-term company management and David, maybe see the new blood Kevin and Jean get involved to provide some details vs the malarkey we have dealt with for years.
Yes, I know there are the AF's, CT's and some other rogue actors out there but Cofer is supposed to be watching all that and dealing with it in the future and we are already pretty much at zero financially so what is there to lose with some straight talk and transparency with investors.
Please chime in with your questions and let’s leave all speculation out of the thread to make it easier for David Innes to follow (we all know he reads this board). We do not need any more infomercials – we need some transparency to rebuild trust or new board of directors that will hold a new management team accountable. I’ll start with some below –
1) Specifically, address what activities have taken place since November 2018 with a timeline so we can see there is forward momentum and build up trust with your community (Doctors, Patients, and Investors)?
2) What steps, in order, are remaining to gain approval in each of the four RA’s with a timeline and what can be occurring simultaneously?
3) What activities are being undertaken to stop the dilution of share price to drive shareholder value and save/prolong people’s lives with minimal side effects?
4) If we continue to move forward at the current pace when will the current team step aside for leadership that knows how to get this to completion?
5) When will the company start doing arm’s length transactions?
6) Why will NWBO not partner with others to stop the dilution and get a product through the pipeline to patients?
7) Why does the company not focus on getting a single task completed vs spending time/energy/funds on other activities that are announced and never heard about again; thus creating false hope for the community and more broken trust. Items such as colorectal cancer with Merck and the UoMainz, DCVax Direct Phase next phase, Drug trails with Merck product, etc. These things just frustrate people and are a tease to both potential patients and investors alike generating many useless cycles of energy expended.
Please add your questions…..
8) ….
9) …….
10) ……….
11) Etcetera
I have a feeling if positive news is not announced prior to and/or at the meeting and if they are requesting an increase in shares, that this will be an interesting meeting for the management, not the investors or potential patients. It is time, we (longs and the angel investors) hold them all accountable (CM, BoD, SAB) and stop the slow drip insanity. Maybe NWBO’s insolvency will allow UCLA and Linda Liau to provide the license and technology to someone that will be successful in getting a new cancer platform to market.
I hope the answer to Question 1 above reflects they have been diligent and working smart the past 17 months (11/2018 – 4/2020), have unblinded, are completing preparation for TLD in "XX" days for the SAP and can provide a specific near-term week the four RA’s will receive the accelerated approval request.
Looking forward to seeing what all questions you longs have in mind and how many are going to ASM. Let's load this up over the weekend so David has some nice reading material Monday morning.
All the best and have a great weekend!
Gloom, Despair, and Agony - video